Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis

被引：2
|
作者：
Ferreira, Joao Pedro [1 ,2 ,3 ]
机构：
[1] Univ Lorraine, Ctr Invest Clin Plurithemat 1433, INSERM, Nancy, France
[2] CHRU, INSERM, U1116, F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France
[3] Univ Porto, Fac Med, Dept Surg & Physiol, Cardiovasc Res & Dev Ctr, Porto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷 / 06期
关键词：
DILATED CARDIOMYOPATHY; HEART-FAILURE; SPIRONOLACTONE;
D O I：
10.1002/ejhf.2216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：945 / 946
页数：2
相关论文
共 50 条
  • [1] Is serum carboxy-terminal propeptide of procollagen type I levels (the indicator of myocardial fibrosis) higher in dipper hypertensive patients?
    Onrat, E
    Serteser, M
    Kaya, D
    Kahraman, A
    Koken, T
    Alpaslan, M
    Melek, M
    JOURNAL OF HYPERTENSION, 2004, 22 : S325 - S325
  • [2] Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
    Querejeta, R
    Varo, N
    López, B
    Larman, M
    Artiñano, E
    Etayo, JC
    Ubago, JLM
    Gutierrez-Stampa, M
    Emparanza, JI
    Gil, MJ
    Monreal, I
    Mindán, JP
    Diez, J
    CIRCULATION, 2000, 101 (14) : 1729 - 1735
  • [3] Early Circulating Procollagen Type I Carboxy-Terminal Propeptide Levels After Acute Myocardial Infarction Correlate With Scar Size
    Driessen, Helen E.
    van Klarenbosch, Bas R.
    Kok, Bart J.
    Vos, Marc A.
    Cramer, Maarten J.
    Chamuleau, Steven A.
    van Veen, Toon A.
    Velthuis, Birgitta K.
    de Jong, Sanne
    CIRCULATION, 2018, 138
  • [4] Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease
    Banerjee, Tanima
    Mukherjee, Somaditya
    Biswas, Monodeep
    Dutta, Santanu
    Chatterjee, Shelly
    Ghosh, Sudip
    Pattari, Sanjib
    Nanda, Navin C.
    Bandyopadhyay, Arun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (01) : 117 - 119
  • [5] Serum levels of carboxy-terminal propeptide of Type 1 procollagen do not reflect the severity of nonalcoholic steatohepatitis
    Okan, Abdullah
    Tankurt, Ethem
    Sabuncuoglu, Defne
    Sonsuz, Abdullah
    Guener, Guel
    Sagol, Oezgul
    Oezbay, Guelsen
    Goenen, Oemuer
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2007, 27 (01): : 27 - 31
  • [6] Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
    Ferreirra, Joao Pedro
    Cleland, John G.
    Girerd, Nicolas
    Rossignol, Patrick
    Pellicori, Pierpaolo
    Cosmi, Franco
    Mariottoni, Beatrice
    Gonzalez, Arantxa
    Diez, Javier
    Solomon, Scott D.
    Claggett, Brian
    Pfeffer, Marc A.
    Pitt, Bertram
    Petutschnigg, Johannes
    Pieske, Burkert
    Edelmann, Frank
    Zannad, Faiez
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 377 : 86 - 88
  • [7] Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Yang, Chengzhi
    Qiao, Shubin
    Song, Yunhu
    Liu, Yun
    Tang, Yajie
    Deng, Long
    Yuan, Jiansong
    Hu, Fenghuan
    Yang, Weixian
    CARDIOVASCULAR PATHOLOGY, 2019, 43
  • [8] Serum carboxy-terminal propeptide of human type I procollagen (PIP) is a marker of myocardial fibrosis in patients with early type 2 diabetes mellitus
    Ihm, S. -H.
    Youn, H. -J.
    Chang, K. -Y.
    Park, C. -S.
    Seung, K. -B.
    Kim, J. -H.
    Hong, S. -J.
    Choi, K. -B.
    EUROPEAN HEART JOURNAL, 2005, 26 : 490 - 490
  • [9] Prognostic value of carboxy-terminal propeptide of type I procollagen in human colorectal carcinoma
    Eryavuz, Y
    Eroglu, A
    Demirci, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 223 - 223
  • [10] PROCOLLAGEN TYPE-I CARBOXY-TERMINAL PROPEPTIDE AS A MARKER OF OSTEOBLASTIC BONE METASTASES
    FRANCINI, G
    GONNELLI, S
    PETRIOLI, R
    BRUNI, S
    MARSILI, S
    AQUINO, A
    CAMPOREALE, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1993, 2 (02) : 125 - 129
12345